Trial Profile
Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic Using Two Hour Neoral Monitoring.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Mycophenolate sodium (Primary) ; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms COBACAM
- 05 Jan 2017 Planned End Date changed from 1 Jan 2017 to 1 Oct 2015.
- 05 Jan 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2015.
- 05 Jan 2017 Planned initiation date changed from 1 Jan 2016 to 1 Feb 2014.